Stay updated on M7824 and Topotecan in Relapsed SCLC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.

Latest updates to the M7824 and Topotecan in Relapsed SCLC Clinical Trial page
- Check4 days agoChange DetectedThe study page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be an administrative update to the record that does not change the study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe site revision label updated from v3.6.4 to v3.6.5, signaling a new deployment of the platform. There is no indication that the content of the study page was changed.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page revision label changed from v3.6.3 to v3.6.4. This reflects a deployment or maintenance update and does not alter the displayed content.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision was updated to v3.6.3, reflecting a new release of the page's UI/content. The study information displayed remains unchanged.SummaryDifference0.0%

- Check82 days agoChange DetectedAdds 'No longer looking for participants' and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with an 'Intervention/Treatment' section, and removes the old 'Intervention / Treatment' heading and the 'Revision: v3.5.5' note; a 'Revision: v3.6.0' update is included.SummaryDifference0.3%

- Check89 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a routine backend/software update to the page.SummaryDifference0.0%

Stay in the know with updates to M7824 and Topotecan in Relapsed SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Topotecan in Relapsed SCLC Clinical Trial page.